No limits in the cloud: Insights proliferate at Eurofins Viracor
With Illumina Connected Analytics, Eurofins Viracor can now analyze complex data sets, freeing them up to make greater discoveries Around the world, sequencing laboratories are experiencing an increase in the demand for clinical next-generation sequencing (NGS). But with that demand comes the possibility of a bioinformatics bottleneck. No one understands this more than Eurofins ...
PODCAST: Precision oncology - an interview with Karina Eterovic
January 19, 2023
Dive into our podcast with Karina Eterovic, R&D Director for Oncology Diagnostics at Eurofins Viracor (KS, USA). Karina gives her insight into the technological advancements made through the increased focus on precision oncology and explains the major challenges faced during drug development.
ON-DEMAND WEBINAR: Opportunities and Challenges of Developing and Validating qPCR Assays in Pivotal Vaccine Trials and Beyond
December 8, 2022 11 am EST
On-Demand AVAILABLE "Opportunities and Challenges of Developing and Validating qPCR Assays in Pivotal Vaccine Trials and Beyond", presented by Dr. Mark Wissel, Director of R&D, Eurofins Viracor Biopharma.
ON-DEMAND WEBINAR: Next-Generation Sequencing Applications for Antiviral Drug Development
November 11, 2022 11 am EST
On-Demand AVAILABLE "Next-Generation Sequencing Applications for Antiviral Drug Development", presented by Dr. Kirthi Kutambuka, Senior Research Scientist, Eurofins Viracor BioPharma